Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
3.33
Dollar change
+0.05
Percentage change
1.52
%
Index- P/E- EPS (ttm)-0.80 Insider Own21.05% Shs Outstand47.40M Perf Week11.00%
Market Cap156.88M Forward P/E- EPS next Y-0.94 Insider Trans0.00% Shs Float37.19M Perf Month-14.83%
Income-36.19M PEG- EPS next Q- Inst Own7.78% Short Float0.08% Perf Quarter-32.45%
Sales39.17M P/S4.01 EPS this Y-1.37% Inst Trans- Short Ratio1.44 Perf Half Y-37.41%
Book/sh-0.49 P/B- EPS next Y19.64% ROA-52.84% Short Interest0.03M Perf Year-41.94%
Cash/sh1.51 P/C2.21 EPS next 5Y- ROE- 52W Range2.76 - 8.96 Perf YTD-54.26%
Dividend Est.- P/FCF- EPS past 5Y8.62% ROI-150.80% 52W High-62.84% Beta0.21
Dividend TTM- Quick Ratio1.42 Sales past 5Y-49.75% Gross Margin- 52W Low20.65% ATR (14)0.31
Dividend Ex-Date- Current Ratio1.42 EPS Y/Y TTM54.68% Oper. Margin-78.29% RSI (14)43.17 Volatility10.74% 8.28%
Employees102 Debt/Eq- Sales Y/Y TTM- Profit Margin-92.38% Recom1.25 Target Price12.70
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q42.11% Payout- Rel Volume2.06 Prev Close3.28
Sales Surprise-2.29% EPS Surprise2.29% Sales Q/Q- EarningsSep 18 AMC Avg Volume21.52K Price3.33
SMA20-1.75% SMA50-19.13% SMA200-37.55% Trades Volume44,279 Change1.52%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated Guggenheim Buy $12
Dec-08-23Initiated Leerink Partners Outperform $11
Jan-06-21Initiated Evercore ISI Outperform
Dec-11-24 04:15PM
Dec-09-24 04:15PM
Nov-13-24 04:15PM
Nov-12-24 02:30AM
Oct-31-24 03:30AM
04:15PM Loading…
Oct-11-24 04:15PM
Sep-18-24 04:15PM
Sep-04-24 04:15PM
Sep-03-24 04:15PM
Aug-08-24 04:15PM
Jul-09-24 04:15PM
Jun-12-24 04:15PM
Jun-11-24 04:15PM
Jun-02-24 10:00AM
May-28-24 04:15PM
04:15PM Loading…
May-23-24 04:15PM
May-22-24 02:00AM
May-21-24 04:15PM
May-16-24 04:15PM
May-15-24 04:15PM
May-14-24 04:15PM
Apr-24-24 04:40PM
Apr-17-24 04:15PM
Apr-13-24 10:02AM
Apr-10-24 04:15PM
Apr-02-24 04:15PM
Mar-06-24 04:15PM
Feb-13-24 04:15PM
Jan-31-24 04:15PM
Jan-30-24 11:02AM
04:15PM Loading…
Jan-29-24 04:15PM
Jan-17-24 08:00AM
Jan-11-24 04:32PM
Dec-26-23 02:00AM
Dec-13-23 04:15PM
Dec-04-23 04:22PM
Nov-13-23 04:15PM
Nov-09-23 04:15PM
Nov-08-23 04:15PM
Nov-07-23 04:01PM
Nov-06-23 02:00AM
Nov-02-23 10:49AM
Nov-01-23 06:32PM
Oct-23-23 02:00AM
Oct-11-23 04:27PM
Oct-04-23 04:30PM
Sep-29-23 04:15PM
Sep-28-23 04:15PM
Sep-26-23 04:15PM
Sep-19-23 04:15PM
Sep-13-23 04:15PM
Sep-05-23 04:15PM
Aug-31-23 04:15PM
Aug-15-23 04:15PM
Aug-04-23 04:15PM
Jul-20-23 04:15PM
Jul-19-23 04:15PM
Jul-10-23 02:00AM
Jun-08-23 04:15PM
May-17-23 04:15PM
May-05-23 01:30AM
Apr-24-23 07:33PM
Apr-17-23 04:15PM
Apr-11-23 04:15PM
Mar-27-23 04:15PM
Mar-14-23 04:15PM
Feb-14-23 04:15PM
Jan-11-23 04:15PM
Dec-27-22 01:45AM
Dec-21-22 04:15PM
Dec-08-22 04:15PM
Nov-15-22 04:15PM
Nov-14-22 04:15PM
Nov-10-22 08:28AM
02:00AM
Nov-09-22 04:15PM
Nov-08-22 04:15PM
Nov-02-22 04:15PM
Oct-31-22 04:15PM
Oct-27-22 04:15PM
Oct-18-22 04:15PM
Oct-10-22 04:15PM
Sep-28-22 04:15PM
Sep-22-22 04:15PM
07:22AM
Sep-21-22 04:15PM
Sep-12-22 02:00AM
Sep-08-22 04:15PM
Sep-07-22 04:15PM
Sep-06-22 04:15PM
Aug-31-22 04:15PM
Aug-09-22 04:15PM
Jul-13-22 04:15PM
Jul-08-22 04:15PM
Jun-09-22 04:15PM
Jun-05-22 09:00AM
Jun-02-22 04:15PM
May-18-22 09:12PM
04:40PM
May-17-22 04:15PM
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Levy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.